Repressed induction of interferon-related microRNAs miR-146a and miR-155 in peripheral blood mononuclear cells infected with HCV genotype 4

FEBS Open Bio

Volumn 2, Issue , 2012, Pages 179-186

  El Ekiaby, Nada ^a   Hamdi, Nabila ^a   Negm, Mohamed ^b   Ahmed, Rasha ^b   Zekri, Abdel Rahman ^c   Esmat, Gamal ^b   Abdelaziz, Ahmed Ihab ^a  

^a German University in Cairo   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

^c CAIRO UNIVERSITY   (Egypt)

Author keywords

HCV; Interferon; MiR 146a; MiR 155; PBMCs; TLR 7

Indexed keywords

ALPHA2A INTERFERON; IMIQUIMOD; MICRORNA 146A; MICRORNA 155; STAT PROTEIN; TOLL LIKE RECEPTOR 7;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VIRUS INTERFERENCE;

EID: 84867305834     PISSN: 22115463     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fob.2012.07.005     Document Type: Article

References (27)

1. Chang J, Guo JT, Jiang D, Guo H, Taylor JM, et al. Liver-specific microRNA miR-122 enhances the replication of hepatitis C virus in nonhepatic cells. J. Virol. 2008, 82:8215-8223.
2. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 2005, 309:1577-1581.
3. Marquez RT, Bandyopadhyay S, Wendlandt EB, Keck K, Hoffer BA, et al. Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans. Lab Invest. 2010, 90:1727-1736.
4. Sarasin-Filipowicz M, Krol J, Markiewicz I, Heim MH, Filipowicz W Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy. Nat. Med. 2009, 15:31-33.
5. Murakami Y, Tanaka M, Toyoda H, Hayashi K, Kuroda M, et al. Hepatic microRNA expression is associated with the response to interferon treatment of chronic hepatitis C. BMC Med. Genomics 2010, 3:48.
6. Pedersen IM, Cheng G, Wieland S, Volinia S, Croce CM, et al. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 2007, 449:919-922.
7. Hou J, Wang P, Lin L, Liu X, Ma F, et al. MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J. Immunol. 2009, 183:2150-2158.
8. Wang P, Hou J, Lin L, Wang C, Liu X, et al. Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1. J. Immunol. 2010, 185:6226-6233.
9. Tang Y, Luo X, Cui H, Ni X, Yuan M, et al. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum. 2009, 60:1065-1075.
10. Zhou H, Huang X, Cui H, Luo X, Tang Y, et al. miR-155 and its star-form partner miR-155* cooperatively regulate type I interferon production by human plasmacytoid dendritic cells. Blood 2010, 116:5885-5894.
11. Taganov KD, Boldin MP, Chang KJ, Baltimore D NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 2006, 103:12481-12486.
12. Kawai T, Akira S Toll-like receptor downstream signaling. Arthritis Res. Ther. 2005, 7:12-19.
13. Linnstaedt SD, Gottwein E, Skalsky RL, Luftig MA, Cullen BR Virally induced cellular microRNA miR-155 plays a key role in B-cell immortalization by Epstein-Barr virus. J. Virol. 2010, 84:11670-11678.
14. Hill JM, Zhao Y, Clement C, Neumann DM, Lukiw WJ HSV-1 infection of human brain cells induces miRNA-146a and Alzheimer-type inflammatory signaling. Neuroreport 2009, 20:1500-1505.
15. Ito M, Masumi A, Mochida K, Kukihara H, Moriishi K, et al. Peripheral B cells may serve as a reservoir for persistent hepatitis C virus infection. J. Innate Immunity 2010, 2:607-617.
16. Nguyen MH, Keeffe EB Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6. Clinic. Gastroenterol. Hepatol.: Official Clin. Pract. J. Amer. Gastroenterol. Assoc. 2005, 3:S97-S101.
17. Zignego AL, Macchia D, Monti M, Thiers V, Mazzetti M, et al. Infection of peripheral mononuclear blood cells by hepatitis C virus. J. Hepatol. 1992, 15:382-386.
18. Ito M, Masumi A, Mochida K, Kukihara H, Moriishi K, et al. Peripheral B cells may serve as a reservoir for persistent hepatitis C virus infection. J. Innate Immunity 2010, 2:607-617.
19. Sidorkiewicz M, Grek M, Jozwiak B, Majda-Stanislawska E, Piekarska A, et al. Expression of microRNA-155 precursor in peripheral blood mononuclear cells from Hepatitis C patients after antiviral treatment. Acta Virol. 2010, 54:75-78.
20. Grek M, Piekarska A, Bartkowiak J, Fendler W, Kuydowicz J, et al. Coordinated increase of miRNA-155 and miRNA-196b expression correlates with the detection of the antigenomic strand of hepatitis C virus in peripheral blood mononuclear cells. Int. J. Mol. Med. 2011, 28:875-880.
21. Rehermann B Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. J. Clin. Invest. 2009, 119:1745-1754.
22. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nature Immunol. 2005, 6:981-988.
23. Roers A, Hochkeppel HK, Horisberger MA, Hovanessian A, Haller O MxA gene expression after live virus vaccination: a sensitive marker for endogenous type I interferon. J. Infect. Diseases 1994, 169:807-813.
24. Stuyver L, Wyseur A, van Arnhem W, Hernandez F, Maertens G Second-generation line probe assay for hepatitis C virus genotyping. J. Clin. Microbiol. 1996, 34:2259-2266.
25. Yoneyama M.KM, Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., Taira K., Akira S., Fujita T. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nature Immunol. 2004, 5:730-737.
26. Samuel CE Antiviral actions of interferons. Clin. Microbiol. Rev. 2001, 14:778-809. table of contents.
27. Fenner JE, Starr R, Cornish AL, Zhang JG, Metcalf D, et al. Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity. Nature Immunol. 2006, 7:33-39.